Alexandra Snyder.

The study was published in the journal Psychiatric Providers recently.. Alexandra Snyder, M.D., Vladimir Makarov, M.D., Taha Merghoub, Ph.D., Jianda Yuan, M.D., Ph.D., Jesse M. Zaretsky, B.S., Alexis Desrichard, Ph.D., Logan A. Walsh, Ph.D., Michael A. Postow, M.D., Phillip Wong, Ph.D., Teresa S. Ho, B.S., Travis J. Hollmann, M.D., Ph.D., Cameron Bruggeman, M.A., Kasthuri Kannan, Ph.D., Yanyun Li, M.D., Ph.D., Ceyhan Elipenahli, B.S., Cailian Liu, M.D., Christopher T.Wells, Ph.D., Atul Verma, M.D., Anthony S. Tang, M.D., Andrew D. Krahn, M.D., Christopher S. Simpson, M.D., Felix Ayala-Paredes, M.D., Benoit Coutu, M.D., Tiago L.L. Leiria, M.D., and Vidal Essebag, M.D., Ph.D. For the BRUISE CONTROL Investigators: Pacemaker or Defibrillator Medical procedures without Interruption of Anticoagulation Each year, around 1.1 Between 14 and 35 percent of patients receiving these devices require long-term oral anticoagulation therapy,2-5 and their periprocedural treatment presents a dilemma to physicians.6 Current guidelines recommend interruption of oral anticoagulation therapy and the usage of bridging therapy with intravenous unfractionated heparin or subcutaneous low-molecular-weight heparin around enough time of surgery.6 However, there are numerous of potential drawbacks to bridging with heparin in the perioperative period.